250美元的代价:诺和诺德减肥神药提前痛失专利保护

Ofweek维科网
Yesterday

近日,仿制药企业山德士(Sandoz)CEO 理查德·塞纳(Richard Saynor)的访谈透露了行业残酷真相:"大型药企往往搞不好仿制药业务,因为我们的核心思维是——当'专利破坏者'。"在这个战场,企业必须精准计算每种专利药的到期时间,通过法律手段缩短原研药保护期,才能在仿制药竞争中抢占先机。而利润越高的药物,厮杀就越惨烈。Saynor随后的爆料,却揭露了一个令人瞠目的行业事故......司...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10